Annual Shareholders Equity
$255.37 M
-$21.58 M-7.79%
December 31, 2023
Summary
- As of February 7, 2025, TERN annual stockholders equity is $255.37 million, with the most recent change of -$21.58 million (-7.79%) on December 31, 2023.
- During the last 3 years, TERN annual shareholders equity has risen by +$186.78 million (+272.30%).
- TERN annual shareholders equity is now -7.79% below its all-time high of $276.94 million, reached on December 31, 2022.
Performance
TERN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$364.47 M
+$145.79 M+66.67%
September 30, 2024
Summary
- As of February 7, 2025, TERN quarterly stockholders equity is $364.47 million, with the most recent change of +$145.79 million (+66.67%) on September 30, 2024.
- Over the past year, TERN quarterly shareholders equity has increased by +$109.10 million (+42.72%).
- TERN quarterly shareholders equity is now at all-time high.
Performance
TERN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
TERN Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -7.8% | +42.7% |
3 y3 years | +272.3% | +42.7% |
5 y5 years | +253.6% | +42.7% |
TERN Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -7.8% | +59.3% | at high | +165.6% |
5 y | 5-year | -7.8% | +5970.1% | at high | +1566.8% |
alltime | all time | -7.8% | +5970.1% | at high | +1566.8% |
Terns Pharmaceuticals Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $364.47 M(+66.7%) |
Jun 2024 | - | $218.68 M(-7.6%) |
Mar 2024 | - | $236.72 M(-7.3%) |
Dec 2023 | $255.37 M(-7.8%) | $255.37 M(-1.2%) |
Sep 2023 | - | $258.43 M(-5.7%) |
Jun 2023 | - | $274.15 M(-4.7%) |
Mar 2023 | - | $287.68 M(+3.9%) |
Dec 2022 | $276.94 M | $276.94 M(+50.8%) |
Sep 2022 | - | $183.69 M(+33.9%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $137.22 M(-7.7%) |
Mar 2022 | - | $148.72 M(-7.2%) |
Dec 2021 | $160.30 M(+133.7%) | $160.30 M(-6.9%) |
Sep 2021 | - | $172.16 M(-5.1%) |
Jun 2021 | - | $181.33 M(-4.6%) |
Mar 2021 | - | $190.00 M(+177.0%) |
Dec 2020 | $68.59 M(+1530.4%) | $68.59 M(-376.0%) |
Sep 2020 | - | -$24.85 M(-690.6%) |
Dec 2019 | $4.21 M(-94.2%) | $4.21 M |
Dec 2018 | $72.23 M | - |
FAQ
- What is Terns Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual shareholders equity year-on-year change?
- What is Terns Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Terns Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of TERN is $255.37 M
What is the all time high annual shareholders equity for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual stockholders equity is $276.94 M
What is Terns Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, TERN annual stockholders equity has changed by -$21.58 M (-7.79%)
What is Terns Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of TERN is $364.47 M
What is the all time high quarterly shareholders equity for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly stockholders equity is $364.47 M
What is Terns Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, TERN quarterly stockholders equity has changed by +$109.10 M (+42.72%)